Pharmaco - Press Releases

Date	Title	Company
24-Jun-2021	Catalyst expert Sinocompound launches educational video series	Sinocompound
24-Jun-2021	Takara Bio enters into a license and supply agreement of RetroNectin® with BioNTech Cell & Gene Therapies GmbH	Takara Bio Inc.
24-Jun-2021	Scipher Medicine Announces PrismRA® Met Primary and Secondary Endpoints in Prospective Observational Study Predicting Inadequate Response to World’s Largest-Selling Drug Class	B3C newswire
24-Jun-2021	The Launch of U-Load Dextramer® with Peptide Receptive MHC I and MHC II Monomers Greatly Expands Flexibility while Ensuring Reliable Sensitivity in Exploring Diversity of Cellular Immune Responses	Immudex
24-Jun-2021	NEW REGULATOR FOR BLOOD CANCER DEVELOPMENT IDENTIFIED	Karl Landsteiner University of Health Sciences
24-Jun-2021	Olink announces the new Explore 3072 high throughput proteomics platform, offering uncompromised data quality with coverage of all major biological pathways	Olink
24-Jun-2021	CellPoint and Lonza Enter Strategic Collaboration to Deliver CAR-T Cells to Patients at Point-of-Care	CellPoint
24-Jun-2021	SP launches SP Hull LyoStar® 4.0 R&D freeze dryer to enhance speed to market in drug development	SP Scientific Products (SP)
24-Jun-2021	4D pharma to present at the Microbiome Movement Drug Development Summit	4D pharma
24-Jun-2021	Vifor Pharma to revise DIAMOND study, readout expected in H2 2021	Vifor Pharma
24-Jun-2021	First wave of National Training Centres established as University of Birmingham joins Advanced Therapies Skills Training Network	The University of Birmingham
24-Jun-2021	KITE’S CELL THERAPY TYPE II VARIATION APPLICATION ACCEPTED FOR ADULT ACUTE LYMPHOBLASTIC LEUKAEMIA	Kite
24-Jun-2021	Cannovum AG enters supply agreement for medical cannabis with Aurora Europe	Cannovum AG
23-Jun-2021	Dermapharm Holding SE: Annual General Meeting approves dividend distribution of EUR 0.88 per share	Dermapharm Holding SE
23-Jun-2021	Dolomite Bio’s distributor list expands globally	Dolomite Bio
23-Jun-2021	Copley Scientific joins the Industries Forum of the Taskforce for Lung Health	Copley Scientific
23-Jun-2021	DARZALEX®▼ (daratumumab) Subcutaneous (SC) Formulation Becomes the First Approved Treatment for Newly Diagnosed Systemic Light Chain Amyloidosis in Europe and Gains an Additional Approval in Pre-Treated Multiple Myeloma	Janssen Pharmaceutical Companies of Johnson & Johnson
23-Jun-2021	Chiesi accelerates path toward full sustainability despite Covid-19 pandemic	Chiesi
23-Jun-2021	Advanced Biological Laboratories Obtained a Derogatory Authorization from the French National Agency for Medicines and Health Products Safety (ANSM) for its UltraGene Assay SARS-CoV-2 452R & 484K & 484Q Mutations	Advanced Biological Laboratories (ABL)
23-Jun-2021	SmiLe alumnus GPX Medical sold its first NEOLA® system	SmiLe Incubator